Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing

Wang, YF; Golesworthy, B; Cuggia, A; Domecq, C; Chaudhury, P; Barkun, J; Metrakos, P; Asselah, J; Bouganim, N; Gao, ZH; Chong, G; Foulkes, WD; Zogopoulos, G

Zogopoulos, G (通讯作者),McGill Univ, Hlth Ctr, 1001 Boul Decarie,Rm EM2-3210, Montreal, PQ, Canada.

JOURNAL OF MEDICAL GENETICS, 2022; 59 (8): 793

Abstract

Background Traditional medical genetics models are unable to meet the growing demand for germline genetic testing (GT) in patients with exocrine pancr......

Full Text Link